IbaĆez, Edna P.
HRN: 01-73-85 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/26/2022
CEFUROXIME 500MG (TAB)
04/26/2022
05/03/2022
ORAL
500mg/tab
BID
UTI, Uncomplicated
Waiting Final Action
Indication: EmpiricEmpirical De-escalation Type of Infection: Urinary TractReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes